Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Rigel Pharmaceuticals Total Assets 2010-2023 | RIGL

Rigel Pharmaceuticals total assets from 2010 to 2023. Total assets can be defined as the sum of all assets on a company's balance sheet.
  
Rigel Pharmaceuticals Annual Total Assets
(Millions of US $)
2023 $117
2022 $134
2021 $167
2020 $110
2019 $148
2018 $139
2017 $119
2016 $78
2015 $132
2014 $154
2013 $226
2012 $310
2011 $257
2010 $187
2009 $141
Rigel Pharmaceuticals Quarterly Total Assets
(Millions of US $)
2023-12-31 $117
2023-09-30 $115
2023-06-30 $117
2023-03-31 $124
2022-12-31 $134
2022-09-30 $116
2022-06-30 $128
2022-03-31 $149
2021-12-31 $167
2021-09-30 $187
2021-06-30 $202
2021-03-31 $216
2020-12-31 $110
2020-09-30 $123
2020-06-30 $138
2020-03-31 $143
2019-12-31 $148
2019-09-30 $156
2019-06-30 $156
2019-03-31 $173
2018-12-31 $139
2018-09-30 $123
2018-06-30 $141
2018-03-31 $99
2017-12-31 $119
2017-09-30 $71
2017-06-30 $85
2017-03-31 $101
2016-12-31 $78
2016-09-30 $89
2016-06-30 $99
2016-03-31 $108
2015-12-31 $132
2015-09-30 $139
2015-06-30 $148
2015-03-31 $166
2014-12-31 $154
2014-09-30 $163
2014-06-30 $182
2014-03-31 $203
2013-12-31 $226
2013-09-30 $240
2013-06-30 $262
2013-03-31 $283
2012-12-31 $310
2012-09-30 $194
2012-06-30 $214
2012-03-31 $234
2011-12-31 $257
2011-09-30 $276
2011-06-30 $290
2011-03-31 $166
2010-12-31 $187
2010-09-30 $201
2010-06-30 $196
2010-03-31 $217
2009-12-31 $141
2009-09-30 $164
2009-06-30 $88
2009-03-31 $114
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.210B $0.117B
Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.411B 31.00
Chugai Pharmaceutical (CHGCY) Japan $54.679B 24.44
Takeda Pharmaceutical (TAK) Japan $42.314B 6.86
Merck (MKGAF) Germany $20.967B 19.78
Astellas Pharma (ALPMY) Japan $18.169B 28.69
Sandoz Group AG (SDZNY) Switzerland $14.745B 0.00
Neurocrine Biosciences (NBIX) United States $14.161B 38.76
Shionogi (SGIOY) Japan $14.115B 12.66
United Therapeutics (UTHR) United States $11.642B 12.41
Catalent (CTLT) United States $10.225B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.726B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.935B 7.62
Revolution Medicines (RVMD) United States $6.854B 0.00
Ionis Pharmaceuticals (IONS) United States $6.117B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Madrigal Pharmaceuticals (MDGL) United States $4.892B 0.00
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.717B 0.00
Summit Therapeutics (SMMT) United States $3.082B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.028B 0.00
Corcept Therapeutics (CORT) United States $2.553B 23.13
PTC Therapeutics (PTCT) United States $2.532B 0.00
Indivior (INDV) United States $2.475B 11.73
Dyne Therapeutics (DYN) United States $2.248B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.075B 11.86
Recursion Pharmaceuticals (RXRX) United States $2.074B 0.00
Ardelyx (ARDX) United States $2.040B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.948B 0.00
Evotec AG (EVO) Germany $1.868B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.820B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.737B 17.95
Avadel Pharmaceuticals (AVDL) Ireland $1.705B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.596B 27.93
Soleno Therapeutics (SLNO) United States $1.508B 0.00
Xencor (XNCR) United States $1.486B 0.00
4D Molecular Therapeutics (FDMT) United States $1.350B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.271B 11.94
Pacira BioSciences (PCRX) United States $1.266B 12.60
Collegium Pharmaceutical (COLL) United States $1.227B 7.55
Enliven Therapeutics (ELVN) United States $1.065B 0.00
Cronos Group (CRON) Canada $1.024B 0.00
Ocular Therapeutix (OCUL) United States $0.955B 0.00
Cassava Sciences (SAVA) United States $0.954B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.950B 0.00
ARS Pharmaceuticals (SPRY) United States $0.945B 0.00
Relay Therapeutics (RLAY) United States $0.932B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.918B 0.00
USANA Health Sciences (USNA) United States $0.876B 14.19
Sage Therapeutics (SAGE) United States $0.839B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.729B 0.00
Siga Technologies (SIGA) United States $0.722B 10.68
Silence Therapeutics (SLN) United Kingdom $0.658B 0.00
Savara (SVRA) United States $0.650B 0.00
Lyell Immunopharma (LYEL) United States $0.602B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.596B 0.00
Exscientia (EXAI) United Kingdom $0.565B 0.00
OmniAb (OABI) United States $0.547B 0.00
Verve Therapeutics (VERV) United States $0.538B 0.00
Altimmune (ALT) United States $0.518B 0.00
KalVista Pharmaceuticals (KALV) United States $0.512B 0.00
ProKidney (PROK) United States $0.505B 0.00
Larimar Therapeutics (LRMR) United States $0.495B 0.00
Korro Bio (KRRO) United States $0.467B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.459B 0.00
Lexeo Therapeutics (LXEO) United States $0.421B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.407B 0.00
Tourmaline Bio (TRML) United States $0.406B 0.00
Esperion Therapeutics (ESPR) United States $0.394B 0.00
Heron Therapeutics (HRTX) United States $0.393B 0.00
Harrow (HROW) United States $0.367B 0.00
Black Diamond Therapeutics (BDTX) United States $0.366B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 20.06
Organogenesis (ORGO) United States $0.329B 62.25
Enanta Pharmaceuticals (ENTA) United States $0.321B 0.00
Aquestive Therapeutics (AQST) United States $0.320B 0.00
Bioventus (BVS) United States $0.314B 0.00
Fractyl Health (GUTS) United States $0.312B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.308B 0.00
ESSA Pharma (EPIX) Canada $0.304B 0.00
Nektar Therapeutics (NKTR) United States $0.288B 0.00
Nanobiotix S.A (NBTX) France $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.287B 0.00
Eliem Therapeutics (ELYM) United States $0.282B 0.00
Xeris Biopharma Holdings (XERS) United States $0.280B 0.00
Pyxis Oncology (PYXS) United States $0.258B 0.00
Foghorn Therapeutics (FHTX) United States $0.255B 0.00
Adherex Technologies (FENC) United States $0.252B 0.00
Aldeyra Therapeutics (ALDX) United States $0.247B 0.00
Lyra Therapeutics (LYRA) United States $0.246B 0.00
Metagenomi (MGX) United States $0.237B 0.00
Avita Medical (RCEL) United States $0.226B 0.00
Conduit Pharmaceuticals (CDT) United States $0.221B 0.00
Acrivon Therapeutics (ACRV) United States $0.217B 0.00
Zevra Therapeutics (ZVRA) United States $0.209B 0.00
Galectin Therapeutics (GALT) United States $0.207B 0.00
Century Therapeutics (IPSC) United States $0.196B 0.00
Telomir Pharmaceuticals (TELO) United States $0.184B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
MediWound (MDWD) Israel $0.177B 0.00
Regulus Therapeutics (RGLS) United States $0.173B 0.00
Innate Pharma SA (IPHYF) France $0.171B 0.00
Prelude Therapeutics (PRLD) United States $0.162B 0.00
Achieve Life Sciences (ACHV) Canada $0.162B 0.00
Incannex Healthcare (IXHL) Australia $0.152B 0.00
CytoDyn (CYDY) United States $0.146B 0.00
Elite Pharmaceuticals (ELTP) United States $0.139B 12.98
Amylyx Pharmaceuticals (AMLX) United States $0.138B 2.90
Cardiol Therapeutics (CRDL) Canada $0.136B 0.00
Karyopharm Therapeutics (KPTI) United States $0.132B 0.00
VAXART, INC (VXRT) United States $0.129B 0.00
GlycoMimetics (GLYC) United States $0.118B 0.00
OptiNose (OPTN) United States $0.114B 0.00
FibroGen (FGEN) United States $0.113B 0.00
Citius Pharmaceuticals (CTXR) United States $0.112B 0.00
Relmada Therapeutics (RLMD) United States $0.111B 0.00
Inotiv (NOTV) United States $0.110B 0.00
PMV Pharmaceuticals (PMVP) United States $0.102B 0.00
Assertio Holdings (ASRT) United States $0.098B 7.92
Vivani Medical (VANI) United States $0.098B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Aclaris Therapeutics (ACRS) United States $0.097B 0.00
AlloVir (ALVR) United States $0.092B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.089B 0.00
Jaguar Animal Health (JAGX) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.083B 0.00
Tempest Therapeutics (TPST) United States $0.082B 0.00
Journey Medical (DERM) United States $0.074B 0.00
Champions Oncology (CSBR) United States $0.070B 0.00
Carisma Therapeutics (CARM) United States $0.067B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.99
Mural Oncology (MURA) Ireland $0.065B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.054B 0.00
Gain Therapeutics (GANX) United States $0.053B 0.00
Unicycive Therapeutics (UNCY) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
VYNE Therapeutics (VYNE) United States $0.037B 0.00
DURECT (DRRX) United States $0.036B 0.00
JanOne (JAN) United States $0.034B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Surrozen (SRZN) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
Nutriband (NTRB) United States $0.027B 0.00
Oncternal Therapeutics (ONCT) United States $0.026B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.025B 0.00
PolyPid (PYPD) Israel $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.53
NRx Pharmaceuticals (NRXP) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 1.03
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.017B 0.00
Indaptus Therapeutics (INDP) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.009B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Acutus Medical (AFIB) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.42
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.66